Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Selank: Evidence Summary
Evidence summary for Selank across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Selank overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Generalized anxiety | Tier C | 4 | Russian clinical trials show anxiolytic effects comparable to benzodiazepines without sedation |
| Cognitive enhancement | Tier C | 2 | Limited evidence for memory and learning improvement |